Genetic Variants Linked with the Concentration of Sex Hormone-Binding Globulin Correlate with Uterine Fibroid Risk
Marina Ponomarenko1, Evgeny Reshetnikov1, Maria Churnosova1
1Department of Medical Biological Disciplines, Belgorod State National Research University, 308015 Belgorod, Russia.
Abstract:
In this study we searched for correlations between polymorphic variants that determine sex hormone-binding globulin concentration (SHBGcon) and uterine fibroids (UFs). The work was performed on a sample of 1542 women (569 with UFs and 973 without UFs [control]), from whom we obtained experimental data on the distribution of nine single-nucleotide polymorphisms (SNPs) affecting the SHBGcon (data confirmed in genome-wide association studies [GWASs]). When searching for associations with UFs, both the independent effects of SNPs and the effects of their SNP-SNP interactions (SNP-SNPints) were taken into account during the "deep study" of the functionality of seven important UF loci and 115 strongly linked [r2 ≥ 0.80] variants (an in silico methodology was used). As the results show, two SHBGcon-related SNPs correlated with UF risk: rs3779195 [T/A] BAIAP2L1 (ORAA = 0.38; 95%CIAA = 0.20-0.91; pperm(AA) = 0.023) and rs440837 [A/G] ZBTB10 (ORGG = 1.93; 95%CIGG = 1.17-3.14; pperm(GG) = 0.010). At the same time, seven SHBGcon-related SNPs interacting with each other (four models of such SNP-SNPints [pperm ≤ 0.01)] were found to influence UF risk. These SHBGcon-related SNPs, determining susceptibility to UF, showed strong functional relevance and were involved in pathways of gene transcription regulation, interactions with hormone ligand-binding receptors, the content control of SHBG, testosterone, liver enzymes, lipids, etc. This study's results demonstrate the effect of significant SHBGcon-related genetic determinants of UF risk.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Sex-linked Disorders
Polygenic Traits
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...


